Do we really think the market is so naive as to place almost all the current value of Neuren on Daybue? And completely ignore every piece of positive news?Anyone doing 30 seconds research on Neuren will know Neurens main value lies in NNZ-2591, and also that the drug has been brilliantly successful so far.
I credit the market with more intelligence than is being suggested. I personally think the share price behaviour is rational considering the near term situation Neuren are in - that being that a TO offer is likely to be announced any day from now, from parties that have plenty resources to play a small ASX companies share price.It was noticeable Jon was happy to confirm there's parties interested in partnering, but it was 'I can't comment' when it came to TOs. We all know what no comment normally means....
Share Price, page-12197
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.58 |
Change
-0.620(4.37%) |
Mkt cap ! $1.710B | |||
| Open | High | Low | Value | Volume |
| $13.88 | $13.91 | $13.29 | $9.389M | 695.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 907 | $13.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.58 | 302 | 2 |
View Market Depth
| Last trade - 14.50pm 08/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |